|
| 36762947 | Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. | Thyroid | 2023 |
| 37333123 | The chromatin landscape of healthy and injured cell types in the human kidney. | bioRxiv | 2023 |
| 35051703 | Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer. | Cancer Treat Res Commun | 2022 |
| 36371941 | Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial. | Lung Cancer | 2022 |
| 35459784 | Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. | Sci Rep | 2022 |
| 35443062 | Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection. | Clin Cancer Res | 2022 |
| 35820397 | Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity. | Cancer Cell | 2022 |
| 35419587 | Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. | Clin Cancer Res | 2022 |
| 35413951 | Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. | Nat Commun | 2022 |
| 35977347 | Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. | JCO Precis Oncol | 2022 |
| 34504346 | Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. | Nat Biotechnol | 2021 |
| 34241781 | Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial. | Adv Ther | 2021 |
| 33522021 | Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck. | Head Neck | 2021 |
| 33603241 | Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. | Nat Med | 2021 |
| 34187851 | Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. | Clin Cancer Res | 2021 |
| 34358341 | Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. | Cancer | 2021 |
| 33198942 | Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC. | Journal of Thoracic Oncology | 2021 |
| 34504347 | Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. | Nat Biotechnol | 2021 |
| 31037378 | Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. | Support Care Cancer | 2020 |
| 32193228 | A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. | Clin Cancer Res | 2020 |
| 31778797 | Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC. | J Thorac Oncol | 2020 |
| 32389639 | Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC. | J Thorac Oncol | 2020 |
| 32327465 | Stereotactic body radiation therapy (SBRT) in the management of pulmonary spindle cell carcinoma. | BMJ Case Reports | 2020 |
| 32761153 | Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. | JAMA Oncol | 2020 |
| 32640131 | A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries. | N Engl J Med | 2020 |
| 31319771 | Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i>BRAF<sup>V600E</sup></i>-Mutated Anaplastic Thyroid Carcinoma. | Thyroid | 2019 |
| 31436504 | Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens. | CRISPR Journal | 2019 |
| 31386610 | Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905). | Journal of Clinical Oncology | 2019 |
| 31254688 | The Effects of Liver Disease on Surgical Outcomes Following Adult Spinal Deformity Surgery. | World Neurosurgery | 2019 |
| 30890156 | Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening. | BMC Genomics | 2019 |
| 30938974 | Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses. | ACS Chemical Biology | 2019 |
| 29635542 | Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. | Ann Oncol | 2018 |
| 30279957 | Outcome analysis of Phase I trial patients with metastatic <i>KRAS</i> and/or <i>TP53</i> mutant non-small cell lung cancer. | Oncotarget | 2018 |
| 29724403 | Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al. | Pract Radiat Oncol | 2018 |
| 29229507 | Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. | Radiother Oncol | 2018 |
| 29438696 | The Integrated Genomic Landscape of Thymic Epithelial Tumors. | Cancer Cell | 2018 |
| 29293386 | Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. | J Clin Oncol | 2018 |
| 29686424 | Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. | Nat Med | 2018 |
| 28026871 | Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. | Cancer | 2017 |
| 28346771 | Cohort study of oncologic emergencies in patients with head and neck cancer. | Head and Neck | 2017 |
| 28727865 | Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study. | JAMA Oncol | 2017 |
| 28428019 | Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. | Pract Radiat Oncol | 2017 |
| 28678827 | Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. | PLoS ONE | 2017 |
| 28452157 | Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. | Head Neck | 2017 |
| 26165417 | Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer. | Am J Clin Oncol | 2017 |
| 28068873 | Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. | Thyroid | 2017 |
| 27785980 | Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma. | Thyroid | 2017 |
| 27776115 | Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. | Nat Genet | 2016 |
| 27148581 | A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia. | Cold Spring Harb Mol Case Stud | 2016 |
| 27330023 | Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial. | Journal of Pain and Symptom Management | 2016 |